Literature DB >> 16717107

Collagenase-2 and -3 mediate epidermal growth factor receptor transactivation by bradykinin B2 receptor in kidney cells.

Yurii V Mukhin1, Monika Gooz, John R Raymond, Maria N Garnovskaya.   

Abstract

We have previously shown that stimulation of extracellular signal-regulated protein kinase (ERK) by bradykinin (BK) in murine inner medullary collecting duct (mIMCD)-3 cells is mediated by epidermal growth factor receptor (EGFR) transactivation. The mechanism of EGFR transactivation seemed to be novel, because it does not require phospholipase C, Ca(2+), calmodulin, protein kinase C, G alpha(i) subunits, or EGFR-B(2) receptor heterodimerization. In this study, we demonstrated the involvement of matrix metalloproteinases (MMPs) in B(2) receptor-induced EGFR transactivation using their broad-spectrum inhibitors batimastat and N-[(2R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-l-tryptophan methylamide (Galardin) (GM-6001). Selective inhibitors for collagenase-2 and -3 (MMP-8 and MMP-13, respectively) blocked BK-induced EGFR phosphorylation and ERK activation, whereas inhibitors for MMP-1, -2, -3, -7, or -9 were without effect. Transfection of mIMCD-3 cells with MMP-8 small interfering RNA (siRNA) resulted in approximately 50% decrease of BK-induced ERK activation. A neutralizing antibody against MMP-13 as well as transfection with MMP-13 siRNA produced a similar effect. Inhibition of both collagenases resulted in approximately 65% decrease of BK-induced ERK activation, supporting roles for both enzymes. Stimulation of mIMCD-3 cells with 10 nM BK increased the activity of collagenases in concentrated culture media within 10 min. Moreover, recombinant MMP-13 and MMP-8, when applied to mIMCD-3 cells for 10 min without BK, stimulated tyrosine phosphorylation of EGFR and caused approximately 250% increase over basal ERK phosphorylation comparable with BK-induced ERK activation. Collagenases-induced ERK activation was inhibited by 4-(3-chloroanilino)-6,7-dimethoxyquinazoline (AG-1478) and thus dependent on EGFR tyrosine kinase activity. This study demonstrates a novel role for collagenase-2 and -3 in signaling of the G(q)-coupled BK B(2) receptor in mIMCD-3 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16717107     DOI: 10.1124/jpet.106.104000

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Bradykinin B2 receptor interacts with integrin alpha5beta1 to transactivate epidermal growth factor receptor in kidney cells.

Authors:  Inga I Kramarenko; Marlene A Bunni; John R Raymond; Maria N Garnovskaya
Journal:  Mol Pharmacol       Date:  2010-04-12       Impact factor: 4.436

2.  β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells.

Authors:  Fabrice Jaffré; Alan E Friedman; Zhaoyang Hu; Nigel Mackman; Burns C Blaxall
Journal:  Circulation       Date:  2012-05-18       Impact factor: 29.690

3.  Thrombin stimulates VSMC proliferation through an EGFR-dependent pathway: involvement of MMP-2.

Authors:  Katarina Smiljanic; Milan Obradovic; Aleksandra Jovanovic; Jelena Djordjevic; Branislava Dobutovic; Danimir Jevremovic; Pierre Marche; Esma R Isenovic
Journal:  Mol Cell Biochem       Date:  2014-07-22       Impact factor: 3.396

4.  Bradykinin decreases podocyte permeability through ADAM17-dependent epidermal growth factor receptor activation and zonula occludens-1 rearrangement.

Authors:  Mamon Dey; Aleksander Baldys; Dezmond B Sumter; Pal Göoz; Louis M Luttrell; John R Raymond; Monika Göoz
Journal:  J Pharmacol Exp Ther       Date:  2010-06-21       Impact factor: 4.030

5.  Identification of functional bradykinin B(2) receptors endogenously expressed in HEK293 cells.

Authors:  Inga I Kramarenko; Marlene A Bunni; Thomas A Morinelli; John R Raymond; Maria N Garnovskaya
Journal:  Biochem Pharmacol       Date:  2008-10-01       Impact factor: 5.858

6.  Genetic Variants of Matrix Metalloproteinase and Sepsis: The Need Speed Study.

Authors:  Nicola Fiotti; Filippo Mearelli; Filippo Giorgio Di Girolamo; Luigi Mario Castello; Alessio Nunnari; Salvatore Di Somma; Enrico Lupia; Efrem Colonetti; Maria Lorenza Muiesan; Giuseppe Montrucchio; Carlo Giansante; Gian Carlo Avanzi; Gianni Biolo
Journal:  Biomolecules       Date:  2022-02-09

7.  The bradykinin B(2) receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines.

Authors:  Inga I Kramarenko; Thomas A Morinelli; Marlene A Bunni; John R Raymond; Maria N Garnovskaya
Journal:  Cancer Manag Res       Date:  2012-07-26       Impact factor: 3.989

8.  Bradykinin inhibits oxidative stress-induced senescence of endothelial progenitor cells through the B2R/AKT/RB and B2R/EGFR/RB signal pathways.

Authors:  Cong Fu; Bing Li; Yuning Sun; Genshan Ma; Yuyu Yao
Journal:  Oncotarget       Date:  2015-09-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.